Astrazeneca
- BusinessAOL
Pfizer withdraws AstraZeneca bid
US drugs giant Pfizer today officially withdrew from its attempt to take over AstraZeneca after the UK-based group repeatedly spurned its advances. Pfizer said in a statement: "On 18 May 2014, Pfizer announced that it had made a final
- BusinessAOL
AstraZeneca rejects new Pfizer bid
AstraZeneca has rejected a final £69 billion takeover offer from US drugs giant Pfizer, saying it undervalued the company. The UK-based pharmaceuticals firm spurned the latest advance from the Viagra maker after it upped the price it was
- BusinessAOL
AstraZeneca braced for hostile bid
Speculation is mounting that US pharmaceutical giant Pfizer is set to make a hostile bid for AstraZeneca after its £63 billion takeover offer was spurned. The UK company said the offer "substantially" undervalued the business, forcing
- BusinessAOL
Pfizer reveals AstraZeneca bid
Drugs giant Pfizer has disclosed details of a £59 billion approach for UK rival AstraZeneca in what would be the biggest foreign takeover of a British firm. Astra has spurned two advances from the Viagra maker since January but the American
- BusinessAOL
AstraZeneca injects £120m into UK site
Drugs giant AstraZeneca is to invest £120 million in a new facility at its global manufacturing site in the UK, securing 300 jobs and creating 200 temporary posts. The development, at the firm's plant in Macclesfield, Cheshire, will lead
- BusinessAOL
Row over drugs firm chief's pension
The departing boss of AstraZeneca will reportedly enjoy a "golden goodbye" worth up to £40 million despite leaving the pharmaceuticals giant with concerns over the development of new drugs. Chief executive David Brennan last week
- NewsAOL
Boss of AstraZeneca to step down
The boss of AstraZeneca has announced he is stepping down as the drug maker slashed its full-year profit hopes following a series of patent setbacks. David Brennan, who has been in the post for six years, will leave on June 1 after coming
